
TY  - JOUR
AU  - Playford, RJ
AU  - Ghosh, S
TI  - Cytokines and growth factor modulators in intestinal inflammation and repair
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 205
IS  - 4
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.1722
DO  - doi:10.1002/path.1722
SP  - 417
EP  - 425
KW  - inflammation
KW  - ulceration
KW  - repair
KW  - growth factors
PY  - 2005
AB  - Abstract Breakdown in gastrointestinal mucosal integrity may be due to increased aggressive factors, including an excessive inflammatory response, decreased mucosal defence or a combination of the two. Our understanding of the control processes underlying these changes has rapidly expanded over the last decade and it is becoming clear that rather than being distinct elements, inflammation and repair are interrelated processes mediated by common cytokines and growth factors, with the division of factors as being a cytokine or a growth factor being somewhat artificial. The use of biological therapies, such as antibodies that cause receptor blockade or administering recombinant growth factors, has now progressed from the laboratory to the clinical arena. This review summarizes current thoughts on the use of these factors in general, but with particular emphasis on inflammatory bowel disease. Copyright ? 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of Gastroenterology and Hepatology
VL  - 26
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.06898.x
DO  - doi:10.1111/j.1440-1746.2011.06898.x
SP  - 16
EP  - 288
PY  - 2011
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 58
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26727
DO  - doi:10.1002/hep.26727
SP  - 208A
EP  - 1309A
PY  - 2013
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Asia-Pacific Journal of Clinical Oncology
VL  - 6
IS  - s3
SN  - 1743-7555
UR  - https://doi.org/10.1111/j.1743-7563.2010.01358.x
DO  - doi:10.1111/j.1743-7563.2010.01358.x
SP  - 100
EP  - 147
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster - Gastroenterology
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 30
IS  - S4
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.13188
DO  - doi:10.1111/jgh.13188
SP  - 28
EP  - 159
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 16
IS  - S3
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.12710
DO  - doi:10.1111/codi.12710
SP  - 37
EP  - 105
PY  - 2014
ER  - 

AU  - Acheson, David W.K.
AU  - Lubin, Lisa F.
C7  - pp. 290-319
TI  - Vulnerable Populations and their Susceptibility to Foodborne Disease
SN  - 9781405122207
UR  - https://doi.org/10.1002/9780470697757.ch5
DO  - doi:10.1002/9780470697757.ch5
SP  - 290-319
KW  - vulnerable populations
KW  - foodborne disease
KW  - physiological defences
KW  - food handling practices
KW  - acquired immunodeficiency syndrome (AIDS)
PY  - 2014
AB  - Summary This chapter contains section titled: Introduction Physiological defences Vulnerable populations Age-related immune deficiency Acquired immunodeficiency syndrome (AIDS) Iatrogenic immune suppression Pregnancy-related immune suppression Factors contributing to foodborne infection Basic food handling practices Food handling practices for vulnerable populations Conclusions References
ER  - 

TY  - JOUR
AU  - Planas, R.
AU  - Carrillo, J.
AU  - Sanchez, A.
AU  - Ruiz de Villa, M. C.
AU  - Nuñez, F.
AU  - Verdaguer, J.
AU  - James, R. F. L.
AU  - Pujol-Borrell, R.
AU  - Vives-Pi, M.
TI  - Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes
JO  - Clinical & Experimental Immunology
VL  - 159
IS  - 1
SN  - 9781405122207
UR  - https://doi.org/10.1111/j.1365-2249.2009.04053.x
DO  - doi:10.1111/j.1365-2249.2009.04053.x
SP  - 23
EP  - 44
KW  - autoimmunity
KW  - human
KW  - islets
KW  - pancreas
KW  - T1D
KW  - transcriptome
PY  - 2010
AB  - Summary Type 1 diabetes (T1D) is caused by the selective destruction of the insulin-producing ? cells of the pancreas by an autoimmune response. Due to ethical and practical difficulties, the features of the destructive process are known from a small number of observations, and transcriptomic data are remarkably missing. Here we report whole genome transcript analysis validated by quantitative reverse transcription?polymerase chain reaction (qRT?PCR) and correlated with immunohistological observations for four T1D pancreases (collected 5 days, 9 months, 8 and 10 years after diagnosis) and for purified islets from two of them. Collectively, the expression profile of immune response and inflammatory genes confirmed the current views on the immunopathogenesis of diabetes and showed similarities with other autoimmune diseases; for example, an interferon signature was detected. The data also supported the concept that the autoimmune process is maintained and balanced partially by regeneration and regulatory pathway activation, e.g. non-classical class I human leucocyte antigen and leucocyte immunoglobulin-like receptor, subfamily B1 (LILRB1). Changes in gene expression in islets were confined mainly to endocrine and neural genes, some of which are T1D autoantigens. By contrast, these islets showed only a few overexpressed immune system genes, among which bioinformatic analysis pointed to chemokine (C-C motif) receptor 5 (CCR5) and chemokine (CXC motif) receptor 4) (CXCR4) chemokine pathway activation. Remarkably, the expression of genes of innate immunity, complement, chemokines, immunoglobulin and regeneration genes was maintained or even increased in the long-standing cases. Transcriptomic data favour the view that T1D is caused by a chronic inflammatory process with a strong participation of innate immunity that progresses in spite of the regulatory and regenerative mechanisms.
ER  - 

AU  - Mally, Angela
C7  - pp. 171-194
TI  - Biomarkers as Tools for Predictive Safety Assessment: Novel Markers of Drug-Induced Kidney Injury
SN  - 9783527336081
UR  - https://doi.org/10.1002/9783527674183.ch09
DO  - doi:10.1002/9783527674183.ch09
SP  - 171-194
KW  - biomarkers
KW  - blood urea nitrogen (BUN)
KW  - drug induced kidney injury
KW  - kidney injury molecule- 1 (KIM-1)
KW  - novel biomarkers
KW  - predictive toxicology
KW  - serum creatinine
PY  - 2010
AB  - Summary The paramount aim of predictive toxicology in drug discovery and development is to assess the safety of drugs for use in humans. This chapter presents drug induced kidney injury as an example to illustrate the value and limitations of novel biomarkers by providing an overview of their (patho) physiological role and mechanistic link to toxicity, performance in experimental toxicity studies, approval by regulatory bodies, and application to preclinical decision making. Traditional markers of renal function such as serum creatinine and blood urea nitrogen (BUN) are inherently insensitive as they indicate kidney injury only when large amounts of the renal epithelium have been lost. The most widely studied urinary kidney biomarker is kidney injury molecule- 1 (KIM-1) encoded by the gene Havr1 (hepatitis A virus cellular receptor 1). Advances in science and technology (e.g., microRNAs, next-generation sequencing) may also offer unique opportunities for the discovery of predictive biomarkers.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 19
IS  - S1
SN  - 9783527336081
UR  - https://doi.org/10.1111/1751-2980.12664
DO  - doi:10.1111/1751-2980.12664
SP  - 12
EP  - 48
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S2
SN  - 9783527336081
UR  - https://doi.org/10.1111/nep.12237
DO  - doi:10.1111/nep.12237
SP  - 77
EP  - 202
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
VL  - 11
IS  - s2
SN  - 9783527336081
UR  - https://doi.org/10.1111/j.1600-6143.2011.03533.x
DO  - doi:10.1111/j.1600-6143.2011.03533.x
SP  - 28
EP  - 211
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Immunology
VL  - 131
IS  - s1
SN  - 9783527336081
UR  - https://doi.org/10.1111/j.1365-2567.2010.03389.x
DO  - doi:10.1111/j.1365-2567.2010.03389.x
SP  - 29
EP  - 51
PY  - 2010
ER  - 

TY  - JOUR
TI  - AMERICAN TRANSPLANT CONGRESS 2012 ABSTRACTS
JO  - American Journal of Transplantation
VL  - 12
IS  - s3
SN  - 9783527336081
UR  - https://doi.org/10.1111/j.1600-6143.2012.04112.x
DO  - doi:10.1111/j.1600-6143.2012.04112.x
SP  - 27
EP  - 542
PY  - 2012
ER  - 

TY  - JOUR
TI  - Summer Meeting 2013. Abstracts of the 7th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 231
IS  - s1
SN  - 9783527336081
UR  - https://doi.org/10.1002/path.4254
DO  - doi:10.1002/path.4254
SP  - 1
EP  - 51
PY  - 2013
ER  - 

TY  - JOUR
TI  - Pathological Society of Great Britain and Ireland. 180th Meeting, 18–21 January 2000
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 190
IS  - 1
SN  - 9783527336081
UR  - https://doi.org/10.1002/path.1711900102
DO  - doi:10.1002/path.1711900102
SP  - A1
EP  - A69
PY  - 2000
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 279
IS  - s1
SN  - 9783527336081
UR  - https://doi.org/10.1111/j.1742-4658.2010.08705.x
DO  - doi:10.1111/j.1742-4658.2010.08705.x
SP  - 52
EP  - 576
PY  - 2012
ER  - 

TY  - JOUR
TI  - Oral
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 30
IS  - S4
SN  - 9783527336081
UR  - https://doi.org/10.1111/jgh.13186
DO  - doi:10.1111/jgh.13186
SP  - 1
EP  - 27
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts of the 76th Annual Meeting of the Japanese Cancer Association; 2017 Sept 28-30; Yokohama, Japan
JO  - Cancer Science
JA  - Cancer Sci
VL  - 109
IS  - S1
SN  - 9783527336081
UR  - https://doi.org/10.1111/cas.13499
DO  - doi:10.1111/cas.13499
SP  - 1
EP  - 1325
PY  - 2018
ER  - 

TY  - JOUR
AU  - Orlandi, Richard R.
AU  - Kingdom, Todd T.
AU  - Hwang, Peter H.
AU  - Smith, Timothy L.
AU  - Alt, Jeremiah A.
AU  - Baroody, Fuad M.
AU  - Batra, Pete S.
AU  - Bernal-Sprekelsen, Manuel
AU  - Bhattacharyya, Neil
AU  - Chandra, Rakesh K.
AU  - Chiu, Alexander
AU  - Citardi, Martin J.
AU  - Cohen, Noam A.
AU  - DelGaudio, John
AU  - Desrosiers, Martin
AU  - Dhong, Hun-Jong
AU  - Douglas, Richard
AU  - Ferguson, Berrylin
AU  - Fokkens, Wytske J.
AU  - Georgalas, Christos
AU  - Goldberg, Andrew
AU  - Gosepath, Jan
AU  - Hamilos, Daniel L.
AU  - Han, Joseph K.
AU  - Harvey, Richard
AU  - Hellings, Peter
AU  - Hopkins, Claire
AU  - Jankowski, Roger
AU  - Javer, Amin R.
AU  - Kern, Robert
AU  - Kountakis, Stilianos
AU  - Kowalski, Marek L.
AU  - Lane, Andrew
AU  - Lanza, Donald C.
AU  - Lebowitz, Richard
AU  - Lee, Heung-Man
AU  - Lin, Sandra Y.
AU  - Lund, Valerie
AU  - Luong, Amber
AU  - Mann, Wolf
AU  - Marple, Bradley F.
AU  - McMains, Kevin C.
AU  - Metson, Ralph
AU  - Naclerio, Robert
AU  - Nayak, Jayakar V.
AU  - Otori, Nobuyoshi
AU  - Palmer, James N.
AU  - Parikh, Sanjay R.
AU  - Passali, Desiderio
AU  - Peters, Anju
AU  - Piccirillo, Jay
AU  - Poetker, David M.
AU  - Psaltis, Alkis J.
AU  - Ramadan, Hassan H.
AU  - Ramakrishnan, Vijay R.
AU  - Riechelmann, Herbert
AU  - Roh, Hwan-Jung
AU  - Rudmik, Luke
AU  - Sacks, Raymond
AU  - Schlosser, Rodney J.
AU  - Senior, Brent A.
AU  - Sindwani, Raj
AU  - Stankiewicz, James A.
AU  - Stewart, Michael
AU  - Tan, Bruce K.
AU  - Toskala, Elina
AU  - Voegels, Richard
AU  - Wang, De Yun
AU  - Weitzel, Erik K.
AU  - Wise, Sarah
AU  - Woodworth, Bradford A.
AU  - Wormald, Peter-John
AU  - Wright, Erin D.
AU  - Zhou, Bing
AU  - Kennedy, David W.
TI  - 过敏和鼻科学国际共识声明 : 鼻窦炎
JO  - International Forum of Allergy & Rhinology
JA  - Int Forum Allergy Rhinol.
VL  - 6
IS  - S1
SN  - 9783527336081
UR  - https://doi.org/10.1002/alr.21695_c
DO  - doi:10.1002/alr.21695_c
SP  - S22
EP  - S209
PY  - 2016
ER  - 
